Recorded on January 31, 2025.

Join us for grand rounds this week where Dr. Kerri Schellenberg, a neuromuscular neurologist at the University of Saskatchewan and director of the ALS/MND clinic and EMG lab at Royal University Hospital in Saskatoon, discusses ALS, the role of the ALS/MND clinic, and the role anesthesiologists' play in the administration of Tofersen.

Kerri Schellenberg MD, MMedED, is an Associate Professor of Neurology at the University of Saskatchewan, and a fellowship trained neuromuscular neurologist. She is the Director of the ALS/MND clinic and Director of the EMG Lab at the Royal University Hospital in Saskatoon. As the current chair of the Canadian ALS (CALS) physician research group, the co-chair of the Neuromuscular Disease for Canada (NMD4C) Clinical Trials Network, and board member for the Scientific Medical Advisory Council (SMAC) for ALS Canada, she has formed multiple national and international research collaborations. Her research includes participation in multiple Phase II and III treatment trials, authorship on the Canadian guidelines for ALS care, publications specific to ALS care in Saskatchewan, and ALS healthcare provider wellness. With a Masters of Medical Education from Dundee University, she has supervised multiple medical students and residents, and serves as the Competency Committee chair for neurology at USask.

Please note that while this podcast is run by healthcare professionals, it is intended for educational and entertainment purposes only. Nothing beats care that is individualized to your own unique medical needs, so if you have any questions about content covered in this podcast that relates to your own health, please speak with your doctor today.

Additionally, the views expressed on this show are our own and do not necessarily represent those of the USask Department of Anesthesiology.